Cancer
Vilcek Foundation appoints Dr. Jedd Wolchok to Board of Directors
The Vilcek Foundation has announced the appointment of Dr. Jedd Wolchok to the board of directors, effective May 1, 2024....
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN
“We have developed a Pix-2-Pix GAN model to perform attenuation correction on whole-body PSMA PET images with 18F-DCFPyL.”Credit: 2024 Ma...
Adding immune-boosting agent to personalized cancer vaccine supercharges the body’s immune defense against malignant brain tumors
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people...
New study reveals how gender affects liver transplant success in cancer patients
A groundbreaking multicenter cohort study in China has illuminated the impact of sex on the outcomes of liver transplantation (LT)...
Scientists pinpoint new vaccine “booster” that promotes potent anti-tumour immunity
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer....
AI advancements make the leap into 3D pathology possible
Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often...
Declination of treatment, racial and ethnic disparity, and overall survival in patients with breast cancer
About The Study: This cross-sectional study highlights racial and ethnic disparities in treatment declination and overall survival, suggesting the need for...
Sylvester Cancer launches new brain tumor institute to personalize brain cancer treatment
MIAMI, FLORIDA (May 8, 2024) – Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine today...
Supercharging immune cells to battle blood cancer: Breakthrough in cancer immunotherapy
A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine...
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival
(WASHINGTON, May 9, 2024) – Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!